Novel TB Regimen With Bayer AG's Antibiotic May Allow Shorter Treatment, Johns Hopkins University School of Medicine Study

April 3 (Bloomberg) -- Bayer AG’s antibiotic Avelox may shave months off the time it takes to cure tuberculosis, according to a study that could help improve treatment rates and fend off drug-resistant forms of the disease.

Back to news